Neuroprotective Effect of Fucoxanthin against Intracerebroventricular Streptozotocin (ICV-STZ) Induced Cognitive Impairment in Experimental Rats
- PMID: 34792011
- DOI: 10.2174/1567205018666211118144602
Neuroprotective Effect of Fucoxanthin against Intracerebroventricular Streptozotocin (ICV-STZ) Induced Cognitive Impairment in Experimental Rats
Abstract
Background: Alzheimer's disease (AD) is a neurological disorder characterized by loss of memory and cognitive functions caused by oxidative stress, neuroinflammation, change in neurotransmitter levels, and excessive deposition of Aβ(1-42) plaques. Fucoxanthin is a carotenoid with potential antioxidant, anti-inflammatory, and neuroprotective actions.
Objective: In the present study, fucoxanthin was employed as a protective strategy in Intracerebroventricular Streptozotocin (ICV-STZ) induced experimental model of cognitive impairment.
Methods: STZ was injected twice ICV (3 mg/kg) on alternate days 1 and 3, and Wistar rats were evaluated for the memory analysis using Morris water maze and elevated plus-maze. Fucoxanthin at low 50 mg/kg, p.o. and high dose 100 mg/kg, p.o. was administered for 14 days. All animals were sacrificed on day 29, and brain hippocampus tissue after isolation was used for biochemical (MDA, nitrite, GSH, SOD and Catalase), neuroinflammatory (TNF-α, IL-1β, and IL-6), neurotransmitters (ACh, GABA Glutamate), Aβ(1-42) and Tau protein measurements.
Results: STZ-infused rats showed significant impairment in learning and memory, increased oxidative stress (MDA, nitrite), reduced antioxidant defense (GSH, SOD and Catalase), promoted cytokine release, and change in neurotransmitters level. However, fucoxanthin improved cognitive functions, restored antioxidant levels, reduced inflammatory markers dose-dependently, and restored neurotransmitters concentration.
Conclusion: The finding of the current study suggests that fucoxanthin could be the promising compound for improving cognitive functions through antioxidant, anti-inflammatory, and neuroprotective mechanisms, and inhibition of acetylcholinesterase (AChE) enzyme activities, Aβ(1-42) accumulation, and tau protein.
Keywords: Alzheimer's disease.; Fucoxanthin; STZ; acetylcholinesterase; cytokines; neurotransmitters.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ (1-42) and NF-kB expression in experimental model of rats.Neurosci Lett. 2023 Mar 16;799:137090. doi: 10.1016/j.neulet.2023.137090. Epub 2023 Jan 20. Neurosci Lett. 2023. PMID: 36690059
-
Protective effect of andrographolide against STZ induced Alzheimer's disease in experimental rats: possible neuromodulation and Aβ(1-42) analysis.Inflammopharmacology. 2021 Aug;29(4):1157-1168. doi: 10.1007/s10787-021-00843-6. Epub 2021 Jul 7. Inflammopharmacology. 2021. PMID: 34235591
-
Protective effect of betulinic acid against intracerebroventricular streptozotocin induced cognitive impairment and neuronal damage in rats: Possible neurotransmitters and neuroinflammatory mechanism.Pharmacol Rep. 2018 Jun;70(3):540-548. doi: 10.1016/j.pharep.2017.11.020. Epub 2017 Dec 6. Pharmacol Rep. 2018. PMID: 29674241
-
Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights.Brain Res Bull. 2023 Feb;193:11-21. doi: 10.1016/j.brainresbull.2022.11.018. Epub 2022 Nov 23. Brain Res Bull. 2023. PMID: 36435362 Review.
-
Mitochondrial protective potential of fucoxanthin in brain disorders.J Nutr Sci. 2024 Jul 25;13:e21. doi: 10.1017/jns.2024.16. eCollection 2024. J Nutr Sci. 2024. PMID: 39776519 Free PMC article. Review.
Cited by
-
Fucoxanthin Inhibits the NMDA and AMPA Receptors Through Regulating the Calcium Response on Substantia Gelatinosa Neurons of the Trigeminal Subnucleus Caudalis in Juvenile Mice.Neural Plast. 2025 Jan 31;2025:2553040. doi: 10.1155/np/2553040. eCollection 2025. Neural Plast. 2025. PMID: 39949835 Free PMC article.
-
The role of sleep deprivation in streptozotocin-induced Alzheimer's disease-like sporadic dementia in rats with respect to the serum level of oxidative and inflammatory markers.Exp Brain Res. 2022 Dec;240(12):3259-3270. doi: 10.1007/s00221-022-06471-y. Epub 2022 Oct 27. Exp Brain Res. 2022. PMID: 36301335
-
Amelioration of intracerebroventricular streptozotocin-induced cognitive dysfunction by Ocimum sanctum L. through the modulation of inflammation and GLP-1 levels.Metab Brain Dis. 2022 Oct;37(7):2533-2543. doi: 10.1007/s11011-022-01056-8. Epub 2022 Jul 28. Metab Brain Dis. 2022. PMID: 35900690
-
Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation.Antioxidants (Basel). 2022 Feb 17;11(2):408. doi: 10.3390/antiox11020408. Antioxidants (Basel). 2022. PMID: 35204290 Free PMC article. Review.
-
Andrographolide Attenuates Short-Term Spatial and Recognition Memory Impairment and Neuroinflammation Induced by a Streptozotocin Rat Model of Alzheimer's Disease.Neurotox Res. 2022 Oct;40(5):1440-1454. doi: 10.1007/s12640-022-00569-5. Epub 2022 Aug 27. Neurotox Res. 2022. PMID: 36029454
MeSH terms
Substances
LinkOut - more resources
Full Text Sources